Clinical stage immunotherapeutic biotechnology company Altimmune Inc ALT today had a large opening gap of 12.28%.
Photo taken from the Opening Gap Signals tool inside Benzinga Pro.
Why Is ALT Moving?
Altimmune shares are trading higher after the company agreed to acquire Spitfire Pharma, which will add a NASH drug candidate to the company's portfolio.
Photo taken from the ‘Why Is It Moving?’ Details tool inside Benzinga Pro.
For live updates on ALT, log in or try Benzinga Pro today.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsPre-Market Outlook
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in